Compile Data Set for Download or QSAR
Report error Found 27 of ic50 data for polymerid = 727
TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412169(US10398702, Example 8 | (3S)-N-[2-[[(3S)-3-[(2,6- ...)
Affinity DataIC50: 2nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412181(US10398702, Example 20 | (S)-N-(2-(((S)-3-((2,6- d...)
Affinity DataIC50: 2nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412171(US10398702, Example 10 | (3S)-2-[(2S)-3,3-dimethyl...)
Affinity DataIC50: 2nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412178(US10398702, Example 17 | tert-Butyl N-[(1 S)-2-[[(...)
Affinity DataIC50: 2nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412176(US10398702, Example 15 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 2nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412183(US10398702, Example 22 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 3nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412182(US10398702, Example 21 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 3nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412180(US10398702, Example 19 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 3nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412179(US10398702, Example 18 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 3nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412165(US10398702, Example 4 | N-(4-(((S)-3-((2,6- difluo...)
Affinity DataIC50: 4nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412166(US10398702, Example 5 | (3S)-2-((S)-3,3-dimethyl-2...)
Affinity DataIC50: 4nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412167(US10398702, Example 6 | (3S)-2-((S)-3,3-dimethyl- ...)
Affinity DataIC50: 4nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412163(US10398702, Example 2 | N-(2-(((S)-3-((2,6- difluo...)
Affinity DataIC50: 6nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412162(US10398702, Example 1 | N-((S)-3-((2,6- difluoroph...)
Affinity DataIC50: 6nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412175(US10398702, Example 14 | N-(2-(4-fluoro-3-((S)-2-(...)
Affinity DataIC50: 7nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412172(US10398702, Example 11 | (3S)-2-[(2S)-3,3-dimethyl...)
Affinity DataIC50: 7nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412177(US10398702, Example 16 | N-(4-(4-fluoro-3-((S)-2-(...)
Affinity DataIC50: 10nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412174(US10398702, Example 13 | tert-Butyl (2R,5S)-4-[2-[...)
Affinity DataIC50: 10nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412168(US10398702, Example 7 | N1-((S)-3-((2,6- difluorop...)
Affinity DataIC50: 10nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412164(US10398702, Example 3 | tert-Butyl (2R,5S)-4-[2-[3...)
Affinity DataIC50: 10nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412187(US10398702, Example D | 4-(6-(4-fluorobenzyl)-3- m...)
Affinity DataIC50: 54nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412170(US10398702, Example 9 | (3R)-N-[2-[[(3S)-3-[(2,6- ...)
Affinity DataIC50: 81nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412184(US10398702, Example A | N-(2-aminoethyl)-6-(4- flu...)
Affinity DataIC50: 81nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412188(US10398702, Example E | 2-(6-(4-fluorobenzyl)-3- m...)
Affinity DataIC50: 100nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412186(US10398702, Example C | 1-(6-(4-fluorobenzyl)-3- (...)
Affinity DataIC50: 103nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412173(US10398702, Example 12 | (R)-N-((S)-3-((2,6- diflu...)
Affinity DataIC50: 160nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetBaculoviral IAP repeat-containing protein 2 [260-351](Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM412185(US10398702, Example B | (S)-6-(4-fluorobenzyl)-3- ...)
Affinity DataIC50: 218nMAssay Description:For the Bir3 assay, 25.5 nanomolar BIR3 domain, corresponding to amino acids 260-352 of cIAP, was mixed with 41 nM of the peptide AVPIAQKSEK-(ε-...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent